Experts in global pathogen research stress the need for universal and comprehensive biosafety measures to address risks associated with handling dangerous microbes. Concerns have been raised regarding biosafety and biosecurity procedures following the COVID-19 pandemic, with discussions on the risks and benefits of viral surveillance and research. Limiting funds for pathogen surveillance compromises pandemic preparedness. Strengthening biosafety measures across the pathogen value chain is essential, including improving collection, transportation, laboratory handling, and waste disposal practices. Collaboration, transparency, and governance are crucial for global safety governance. The scientific community, policymakers, and funding bodies must prioritize biosafety, responsible oversight, and pandemic preparedness to ensure safe and ethical scientific practices.
Source link